Viz.ai

Executive Summary

Viz.ai is a San Francisco-based digital health company leveraging artificial intelligence to transform care coordination for time-sensitive medical conditions. Its platform analyzes medical imaging data using over 50 FDA-cleared algorithms, enabling rapid diagnosis and streamlined workflows. By connecting patients, clinicians, and life-saving treatments, Viz.ai addresses critical bottlenecks in emergency care, such as stroke, pulmonary embolism, and aortic dissection. The company's AI-driven approach reduces time-to-treatment and improves patient outcomes, positioning it as a leader in the AI-enabled healthcare space. Founded in 2016, Viz.ai has built a robust regulatory moat with its extensive library of FDA-cleared algorithms and partnerships with leading health systems. The platform's ability to integrate seamlessly into existing hospital workflows and its focus on high-acuity conditions drive strong adoption. With growing demand for AI in diagnostics and care coordination, Viz.ai is well-positioned to expand into new therapeutic areas and capture a larger share of the digital health market. However, as a private company, financial visibility is limited, and competition from larger tech entrants remains a risk.

Upcoming Catalysts (preview)

• Q3 2026New FDA clearance for cardiac or oncology algorithm70% success
• Q4 2026Major health system contract win65% success
• Q2 2027Series C or later funding round55% success